T Man Pharmaceutical PCL
T.Man Pharmaceutical Public Company Limited manufactures and sells pharmaceuticals and health care products in Thailand. The company operates through three segments: Manufactured Products Under Own Brand, Manufactured Products Under Third Parties' Brand, and Trading Products. It offers antibacterial, central nervous system, corticosteroid, chronic diseases, gastrointestinal, respiratory, and musc… Read more
Market Cap & Net Worth: T Man Pharmaceutical PCL (TMAN)
T Man Pharmaceutical PCL (BK:TMAN) has a market capitalization of $147.66 Million (฿5.12 Billion) as of March 19, 2026. Listed on the BK stock exchange, this Thailand-based company holds position #23932 globally and #323 in its home market, demonstrating a -2.29% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying T Man Pharmaceutical PCL's stock price ฿12.80 by its total outstanding shares 400004000 (400.00 Million).
T Man Pharmaceutical PCL Market Cap History: 2024 to 2026
T Man Pharmaceutical PCL's market capitalization history from 2024 to 2026. Data shows growth from $169.58 Million to $147.66 Million (0.00% CAGR).
T Man Pharmaceutical PCL Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how T Man Pharmaceutical PCL's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of TMAN by Market Capitalization
Companies near T Man Pharmaceutical PCL in the global market cap rankings as of March 19, 2026.
Key companies related to T Man Pharmaceutical PCL by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #422 globally with a market cap of $51.61 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #432 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #452 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #422 | Zoetis Inc | NYSE:ZTS | $51.61 Billion | $117.35 |
| #432 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.31 |
| #452 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
T Man Pharmaceutical PCL Historical Marketcap From 2024 to 2026
Between 2024 and today, T Man Pharmaceutical PCL's market cap moved from $169.58 Million to $ 147.66 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ฿147.66 Million | +24.27% |
| 2025 | ฿118.82 Million | -29.93% |
| 2024 | ฿169.58 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of T Man Pharmaceutical PCL was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $147.66 Million USD |
| MoneyControl | $147.66 Million USD |
| MarketWatch | $147.66 Million USD |
| marketcap.company | $147.66 Million USD |
| Reuters | $147.66 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.